A Radiological Evaluation of Radiolucent Cages Containing Autogenous Bone Graft or Bovine Hydroxyapatite (BH) in Cervical Fusion: a Retrospe

ctive Study in 46 Consecutive Patients

Wei-Chieh Chang, Hsi-Kai Tsou, Wen-Shian Chen ¹, Chi-Chang Chen ¹,Ting-Hsien Kao, Chiung-Chyi Shen

Department of Neurosurgery, Taichung Veterans General Hospital, Taiwan

¹Department of Radiology, Taichung Veterans General Hospital, Taiwan

Purpose: Anterior cervical discetomy and fusion (ACD

F) with PEEK cages are widely used as the surgical treatment of cervical spondylosis.

Cages containing cancellous bone can improve the bony fusion. However, donor site pain is still the major problem.

Hydroxyapatite graft is then introduced as substitute materials. The authors investigated the radiological results in cervical fusion with radiolucent cages between cancellous bone and bovine hydroxyapatite graft.

Materials and Methods: From July 2004 to May 2006, there wer

e 46 consecutive cases of 109 levels of cervical degenerative disease between C2 and C7.

A retrospective analysis of cage fillers were divided into two groups: Group A (23 patients with 56 levels) packed with bone marrow and group B (23 patients with 53 levels) packed with bovin hydroxyapatite graft.

Surgical procedure: Smith-Robinson right side and anterior lateral approach followed by neck collar 8-12 weeks

Radiological results were evaluated by two neuroradiologists blinded to any clinical data.

Bone fusion was defined by the presence of bony trabeculation across the graft-host interfaces

The Prolo scale and Odom’s criteria : economic and functional status

The fusion was evaluated at intervals of 4, 12 and 24 weeks.

Patients inclusion criteria:

>Failure in conservative therapy -- traction, physical or chiropractic therapy, radiofrequency and pharmacotherapy

Surgical levels :

>Neurologic deficits correlated with MRI and/or EMG/NCV findings

ResultsJuly 2004 to May 2006, 46 consecutive cases of 109 levels

Mean follow up 14.1 months

autogenous bone graft sinbone

Characteristic ( n = 23 ) ( n = 23 )

Sex

Men 14 ( 60.9 % ) 13 ( 56.5 % )

women 9 ( 39.1 % ) 10 ( 43.5 % )

Age 51.39 ± 2.27 ( 31 - 73 ) # 59.39 ± 2.92 ( 30 - 79 ) #

CAGE

PEEK1 11 17

CFRP2 12 6

Affected level(total)

( n = 56 ) ( n = 53 )

C2-3 1

2

C3-4 10 12

C4-5 19(33%) 18(34%)

C5-6 20(36%) 16(30%)

C6-7 6 5

One level 3 4

Two levels 9 9

Three levels 9(39%) 7(30%)

Four levels 2 3

Radiculopathy 18(78%) 22(41%)

Myelopathy 5(22%) 11(48%)

Neck pain 5(22%) 2(8%)

Arm pain 13(57%) 16(70%)

0

5

10

15

20

25

C2-3 C3-4 C4-5 C5-6 C6-7

Autogenousgone graft

Sin bone

0

5

10

15

20

25

Autogenousgone graft

Sin bone

0123456789

10

onelevel

twolevel

threelevel

fourlevel

Autogenousgone graft

Sin bone

Table : Prolo ScoreEconomic Status Functional Status

E1 Complete invalid F1 Total incapacity(or worse than before operation)

E2 No gainful occupation including ability to do housework or continue retirement activities

F2 Mild to moderate level of lower back pain and/or sciatica (or pain same as before operation) but able to perform all daily tasks of living.

E3 Able to work but not at previous occupation

F3 Low level of pain and able to perform all activities except sports

E4 Working at previous occupation part-time or limited status

F4 No pain, but patient has had one or more recurrences of lower back pain or sciatica

E5 Able to work at previous occupation with no restrictions of any kind

F5 Complete recovery, no recurrent episodes of lower back pain, able to perform all previous sports activities

Table2. poro scale(A/S兩組及前後比較 )

autogenous bone graft sinbone

Parameter Mean SEM Mean SEM p-value m

poro scale p < 0.001 f** p < 0.001 f**

術前 (0) 0.15 0.13 0.143

術後 1 (1) 5.91 (1)>(0) **@ 0.20 6.00 (1)>(0) **@ 0.29 0.285

術後 2 (2) 6.61 (2)>(0) **@ 0.38 6.65 (2)>(0) **@ 0.34 0.677

術後 3 (3) 7.26 (3)>(0) **@ 0.39 7.43 (3)>(0) **@ 0.38 0.487

m Mann-Whitney U test. f Friedman test. @ Wilcoxon signed-rank test.

*:p<0.05 **:p<0.01

註：Mann-Whitney U test = A與 S兩組之比較差異 (類似 independent t test)

Friedman test = 四組術前術後之總比較

Wilcoxon signed-rank test = 術前術後兩兩較

4.04 3.74

Month

baseline 1 3 6

Sco

re

3

4

5

6

7

8

9

autogenous bone graftsinbone

**

**

**

Fusion

1. Two neuroradiologists blinded with clinical data

2. Post-op, 4 weeks, 12 weeks and 24 weeks

3. Lateral view of X-Ray

4. Osseous trabecular bone across the interface, trabecular bridging bone formation at the anterior and/or posterior cortex of the involved vertebral bodies, lucencies between cage and vertebral plates

Mrs Ju, 44 F, nuchal pain with radiating to right arm and lower limbs weakness for 6 months

CSMR, C3/4/5/6

1 M

4M fusion

Mr. Liao, 49 M C4/5/6 Nuchal pain with radiating to LEFT arm for 1 year

fusion

1 mPost-op

Mr. Yang, 64 M, C3-4, 6-7 CSMR, progressive nuchal pain with radiating to upper arms and lower limbs weakness for 2 years

Post-op

1 MFusion

Table3. Fusion, excellent outcome rates in both groups

autogenous bone graft sinbone

p-valueParameter

No. of patients / total

% No. of patients /

total%

Fusion rate

1 month 12 / 56 21.4 % 9 / 53 17.0 % 0.730

3 month 43 / 56 76.8 % 39 / 53 73.6 % 0.869

6 month 56 / 56 100.0 % 53 / 53 100.0 % －

Odom’s criteria Excellent and good outcome rate

14 / 23 60.9 % 18 / 23 81.8 % 0.222

Yate's correction of contigency is used.

Complications

Autogenous bone graft

Sin bone

Iliac crest morbidity

Pain 18 0

Hematoma 1 0

Infection 0 0

Nerve injury 0 0

Interbody fusion

Breaking 0 0

Pull out 0 0

Subsidence 0 0

Pseudo-arthrosis 0 0

Re-open 1 0

Discussion Anterior approach to the cervical spine Cloward ( J. Neurosurg 15:602-16 ,1958),

Smith and Robinson (J. Bone Joint Surg Am 44:1569-87, 1962 )

Kyphotic angulation, narrowing foramina, loss normal sagittal alignment >> fusion

Waters and Levinthal (Spine 19:2343-7, 1994) fusion with iliac crest bone graft

Donor site chronic pain(22%), hematoma, fracture, paresthetica (Spine 28:134-9 ,2003 )

Cages: immediate stability, resist axial displacement, minimize neck pain, maintain foraminal height and alignment, no donor site pain

Threaded titanium cage, polyestherstherketone (PEEK) cage, carbon fiber reinforced polymer (CFRP) cage containing autogenous bone graft for osteoconduction and osteoinduction, the mean time of fusion is less

Reduce the complication rate by 22% in comparison with autogenous iliac crest graft fusion --J Spinal Disord 13:511–514, 2000.

The PEEK cage is therefore a good substitute for AICG fusion in patients with cervical disc disease. --Neurosurgery 51:1343-1350, 2002

Radiolucent cage: similar elasticity behavior, no MR signal distortion in follow-up, evaluation in fusion

Sinbone® (Purzer, TWN) : Ceramic from bovine cancellous bone:Ca10(PO4)6(OH)2

>> Osteoconductors, lack osteoinductive properties

Osteoinductive factors: osteoblast progenitor cells – periosteum, peritrabecular connective tissue and bone marrow ~J Cell Biocem 1994, 56:283-94

Osteoprogenitor cells were significantly more abundant in the iliac. It is advisable that iliac crest bone marrow would enhance vertebral interbody fusion. - Eur Spine J 2005, 14:645-8

In most studies, the cages were filled with autogenous bone taken from the iliac crest

~Acta Neurochir 1998 140:1-8

Radiolucent cage containing BH

The fusion rate is better in group A (21.4%) then in group B(17%) in first month (No statistical significant p=0.73) No difference in six months after OP

Poro scale: No statistical significant in pre-op, post-op 4,8 and 12 weeks between both groups

Odom’s criteria excellent and good outcome rate (group A: 60.9%, group B: 81.8%, p=0.22). >> Myelopathy: Group A/B: 22%/48% >> Donor site pain: Group A/B: 78%/0%

Conclusion

Hydroxyapatite is a good substitute material as a cage filler

There were no donor site complications The cervical fusion rate, postoperative Poro s

cale and Odom’s criteria had no difference. Extended studies on these patient are indicat

ed and are currently underway in our surgical group.

Comment…..